TUFM Human Pre-designed siRNA Set A contains three designed siRNAs for TUFM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUFT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUFT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUG-2099 (compound 4s) is a potent GPR84 agonist with the EC50 of 0.3 nM. TUG-2099 can be used for study of Alzheimer’s disease, atherosclerosis, cancer, and so an[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity and good solubility, in vitro permeability and microsomal stability[1].

TUG1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TULP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TULP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TULP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TULP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TULP3 Human Pre-designed siRNA Set A contains three designed siRNAs for TULP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TULP4 Human Pre-designed siRNA Set A contains three designed siRNAs for TULP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tuna AI, an angiotensin-converting enzyme (ACE) inhibitor, exhibits IC50 values of 1 μM and 2 μM for ACEs from bovine and rabbit lungs, respectively[1].

TUSC2 Human Pre-designed siRNA Set A contains three designed siRNAs for TUSC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUSC3 Human Pre-designed siRNA Set A contains three designed siRNAs for TUSC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUT4 Human Pre-designed siRNA Set A contains three designed siRNAs for TUT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUT7 Human Pre-designed siRNA Set A contains three designed siRNAs for TUT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TWF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWF2 Human Pre-designed siRNA Set A contains three designed siRNAs for TWF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWIST1 Human Pre-designed siRNA Set A contains three designed siRNAs for TWIST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWIST2 Human Pre-designed siRNA Set A contains three designed siRNAs for TWIST2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWNK Human Pre-designed siRNA Set A contains three designed siRNAs for TWNK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TWSG1 Human Pre-designed siRNA Set A contains three designed siRNAs for TWSG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXK Human Pre-designed siRNA Set A contains three designed siRNAs for TXK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXLNA Human Pre-designed siRNA Set A contains three designed siRNAs for TXLNA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXN Human Pre-designed siRNA Set A contains three designed siRNAs for TXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXN2 Human Pre-designed siRNA Set A contains three designed siRNAs for TXN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC11 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC12 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC15 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC16 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC17 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNDC5 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNDC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNIP Human Pre-designed siRNA Set A contains three designed siRNAs for TXNIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNL1 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNL4A Human Pre-designed siRNA Set A contains three designed siRNAs for TXNL4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNRD1 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNRD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TXNRD2 Human Pre-designed siRNA Set A contains three designed siRNAs for TXNRD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TYK2 Human Pre-designed siRNA Set A contains three designed siRNAs for TYK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tyk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tyk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tyk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tyk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tyk2-in-15 (Compound 97) is a selective tyrosine kinase 2 (Tyk2) inhibitor with IC50 value ≤ 10 nM for Tyk2-JH2. Tyk2-IN-15 can be used in the study of inflammatory or autoimmune diseases[1].

Tyk2-IN-16 is a selective and potent TYK2 inhibitor with an IC50 of

Tyk2-IN-17 (compound 185) is a potent TYK2 inhibitor[1].

Tyk2-IN-18-d3 (Compound 18) is a Tyk2 inhibitor with an IC50 value of < 30 nM for both IL-23 and IFNα. Tyk2-IN-18-d3 can be used for research on autoimmune diseases[1].

Tyk2-IN-18-d5 (Compound 13) is the deuterated TYK2 inhibitor, targeting to JH2 domain. Tyk2-IN-18-d5 can be used for the research of inflammatory and autoimmune diseases[1].